Navigation Links
Dr. Ajaz Hussain Joins ValGenesis Board of Directors
Date:9/12/2017

SAN FRANCISCO, Sept. 12, 2017 /PRNewswire/ -- ValGenesis Inc., the global leader in Enterprise Validation Lifecycle Management Solutions (VLMS), is pleased to announce the appointment of Dr. Ajaz Hussain as a member of its Board of Directors and Chairman of Advisory Board beginning September 8th, 2017. ValGenesis VLMS enables life science companies to manage their entire validation lifecycle process electronically and eliminate the use of paper in this process. Furthermore, ValGenesis VLMS enables rigorous compliance, helps to address data integrity concerns, improve consistency, significantly reducing validation cycle time and removing inefficiencies that plague paper-based validation processes.

Changing regulations, adoption of new technologies and increasing demands across geographies around Validation and regulatory compliance have compelled ValGenesis Inc. to bring forth a proactive and continuous improvement program which aims to deliver useful results. In this endeavor, Dr. Ajaz Hussain will guide and advise ValGenesis product strategy team to meet the evolving global regulatory requirements.

Dr. Ajaz Hussain brings a wealth of international pharmaceutical regulatory and business experience to ValGenesis, including his decade-long tenure with the United States Food and Drug Administration (US FDA), Center for Drug Evaluation and Research (CDER). He has led some of the US Food and Drug Administration's major initiatives to develop regulatory policies that already have and are likely to continue to have a significant impact on product development and approval in many geographies. US FDA has honored him on multiple occasions for his outstanding contributions and innovative scientific approach to resolve complex regulatory and compliance challenges.

Dr. Ajaz Hussain is an advisor to my companies via his namesake consulting firm Insight Advice and Solutions LLC). He also currently serves as the President of The National Institute for Pharmaceutical Technology and Education, a not-for-profit educational organization which is a collaboration of 17 major universities in the U.S. Grants from US FDA primarily fund the research and training programs.

Dr. Ajaz Hussain has over 100 publications to his credit. He is a Fellow of the American Association of Pharmaceutical Scientists and the Swiss Society of Pharmaceutical Sciences. Also worked as top management with Sandoz AG in Germany and Philip Morris International in Swiss, and Wockhardt Limited in India.

"ValGenesis is excited to have Dr. Ajaz Hussain on its Board and as the Chairman of the advisory board. Dr. Ajaz Hussain is one of the architects for science-based approaches to quality and compliance at FDA. His expertise and experience as Deputy Director of FDA and as a life sciences commercial executive will help to evolve ValGenesis VLMS on par with evolving regulatory requirements and industry needs.

ValGenesis VLMS has been implemented as system records for validation process by top 10 out of 20 global life science companies. We have increased responsibility to align our product roadmap with evolving regulatory landscape to help our clients to enable/enforce the current regulatory requirements. We firmly believe that this collaboration will help ValGenesis VLMS become a de-facto standard on how Validation Lifecycle should be assured and managed across the global life science companies," said Dr. Siva Samy, CEO & Chief Product Strategist of ValGenesis, Inc.

"As a first mover in the market, ValGenesis is demonstrating the value of the electronic validation lifecycle management system to global life science companies. Companies adopting ValGenesis are realizing significant improvement (consistency, compliance and cycle time reduction) in their validation processes. With increasing regulatory focus on science based validation, to ensure an adequate level of statistical confidence, I expect the ValGenesis software solution will be invaluable in implementing rigorous validation program. I am excited to support ValGenesis in their continual efforts in pursuit of excellence. This is an exciting opportunity to anticipate the evolving regulatory requirements and help to define the best practices for ValGenesis VLMS so that life science companies can more confidently deliver high-quality products, in time, to patients around the world," remarked Dr. Ajaz Hussain.

About ValGenesis
ValGenesis, Inc. is the creator of an innovative software platform serving as the foundation for managing compliance-based validation activities in Life Sciences companies. ValGenesis, Inc. provides the first enterprise application to manage the corporate validation lifecycle process. As the only system for managing validation execution and approval 100% electronically, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award. The solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements. For more information, visit ValGenesis' website at http://www.valgenesis.com.

Media Contact:
Mike Beaudro
510-445-0505 Ex. 1002 
175732@email4pr.com

View original content with multimedia:http://www.prnewswire.com/news-releases/dr-ajaz-hussain-joins-valgenesis-board-of-directors-300517634.html


'/>"/>
SOURCE ValGenesis Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Ash Keswani Joins Cogentix Medical as SVP of Marketing and Business Development
2. Dr. Yolanda Chong Joins Recursion Pharmaceuticals to Advance Discovery Platform
3. Labor Commissioner Mark Butler Joins Atlanta Businesses at the EFWorks Launch Forum
4. QIAGEN Joins CANCER-ID Consortium for Liquid Biopsy Workflows
5. Dr. Carl H. June, Cancer Immunotherapy Pioneer, Joins CytoSorbents Scientific Advisory Board
6. AdvaMed Joins Global Initiative to Address Growing Burden of Cancer Worldwide
7. Steve Way Joins LifeVac as Official Spokesperson
8. Richard R. Smith Joins EMD Serono as Senior Vice President and Head of US Fertility and Endocrinology
9. Collaboration for Innovation: The Kinetix Group Joins the Prestigious LAN Committed Partnership to Drive Healthcare Payment Reform
10. Physician General Joins State Veterans Affairs Medical Official and Area Agency on Aging Representative to Fill Naloxone Prescription at Pharmacy Using Standing Order
11. Biotech Scientist Teresa Gonzalo Joins M+A Advisory Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2017)... Sept. 1, 2017  Bayer will present the latest research ... for Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... new preclinical and clinical data on Bayer,s marketed portfolio and ... projects. "We value ... in cancer research at ESMO," said Carsten Brunn , ...
(Date:8/29/2017)... Aug. 29, 2017 In a move that ... regulatory compliance for veterinary practices of all sizes, Cubex ... partnership that makes TITAN,s expertise in physical security, drug ... Cubex,s clients nationally. ... handling controlled substances is at risk today," said TITAN ...
(Date:8/25/2017)... ), an Irish medtech company, today announced that it has commenced working ... Bassetlaw, England . The collaboration sees the company,s ... national NHS Test Bed programme exploring new models of care. ... Innovation Zed ... accessory for disposable insulin pen users, automatically collects and records pen usage ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... The ... “Humans With Vaginas.” The goal is to ignite conversation via social media and ... products. The brand has declared September “Humans with Vaginas” month, releasing a video ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... of older Americans at risk of price gouging for their prescription drugs, according ... (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency in ...
(Date:9/20/2017)... ... , ... “The Trials I Face to Receive God’s Grace”: a mesmerizing ... and goals to better one’s life through God. “The Trials I Face to Receive ... the wrong places, found a love for writing. Green feels that expressing his feelings ...
(Date:9/20/2017)... Texas (PRWEB) , ... September 20, 2017 , ... Houston, ... entire team took Friday, September 8, and Monday, September 11, off work and rolled ... Second Baptist Church before heading to local homes to start the process of rebuilding. ...
(Date:9/20/2017)... ... 2017 , ... “The Foggy Road to Moorwick”: the adventures of a young Scottish girl yearning ... author, Jeanine Liston, a busy mother of five who used her time waiting for children ... book for over twenty years. It was a way to give some meaning to ...
Breaking Medicine News(10 mins):